Broken Promise

Saturday, 31 May 2025, 6:37 pm | Rob Crozier

Just 15 Chronic Lymphocytic Leukaemia  patients p/a are expected to benefit from the funding largesse,” said Dr Ruth Spearing, “and of these 15, 5 approvals are for Bendamustine  — a derivative of nitrogen mustard, which was originally developed ... More >>